Key terms

About CGEN

Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses on research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest CGEN news

Mar 08 7:20am ET Analysts Offer Insights on Healthcare Companies: Cigna (CI), Compugen (CGEN) and OrthoPediatrics (KIDS) by TipRanks Mar 07 10:29am ET Biotech Alert: Searches spiking for these stocks today by TipRanks Mar 06 11:18pm ET Buy Rating Justified by Compugen’s Positive Clinical Outlook and Financial Stability by TipRanks Mar 05 7:03am ET Compugen reports Q4 EPS 11c, consensus 22c by TipRanks Feb 15 7:11am ET Compugen names Michelle Mahler M.D. as Chief Medical Officer by TipRanks Jan 08 7:16am ET Compugen to receive $10M milestone payment from AstraZeneca by TipRanks Dec 22 11:14am ET Biotech Alert: Searches spiking for these stocks today by TipRanks Dec 21 9:30pm ET Wall Street Analysts Are Bullish on Top Healthcare Picks by TipRanks Dec 21 9:05pm ET Compugen (CGEN) Receives a Buy from Stifel Nicolaus by TipRanks Dec 21 10:52am ET Biotech Alert: Searches spiking for these stocks today by TipRanks Dec 21 1:26am ET Compugen’s Strategic Partnership with Gilead Bolsters Financial Position and Promises Growth by TipRanks Dec 19 3:52pm ET Compugen spikes after deal with Gilead for anti-tumor drug by TipRanks Dec 19 3:48pm ET Compugen spikes 180% on $848M deal with Gilead for anti-tumor drug by TipRanks Dec 19 7:13am ET Compugen eligible to receive $10M payment upon dosing of AstraZeneca trial by TipRanks Dec 19 7:06am ET Gilead and Compugen in license deal for novel pre-clinical immunotherapy program by TipRanks

No recent news articles are available for CGEN

No recent press releases are available for CGEN

CGEN Financials

1-year income & revenue

Key terms

CGEN Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

CGEN Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

Donald Trump might no longer own a majority of TMTG after a new public share offering.
Joe Raedle/Getty Images
Trump stock tanks after announcing massive share sale
1040 US Individual Income Tax Return Form
Nora Carol Photography/Moment RF/Getty Images
Three ways investors can minimize their tax payments
People walk past the New York Stock Exchange (NYSE) on April 10, 2024 in New York City.
Spencer Platt/Getty Images
Dow closes nearly 500 points lower on fears of potential Iranian attack on Israel
JPMorgan beat earnings expectations this Friday, unofficially kicking off the first quarter earnings season.
Win McNamee/Getty Images
Jamie Dimon says chance of a bad economy is ‘higher than other people think’